ATE94401T1 - Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon. - Google Patents

Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.

Info

Publication number
ATE94401T1
ATE94401T1 AT89810317T AT89810317T ATE94401T1 AT E94401 T1 ATE94401 T1 AT E94401T1 AT 89810317 T AT89810317 T AT 89810317T AT 89810317 T AT89810317 T AT 89810317T AT E94401 T1 ATE94401 T1 AT E94401T1
Authority
AT
Austria
Prior art keywords
processes
production
pharmaceutical compositions
physiological substances
substances
Prior art date
Application number
AT89810317T
Other languages
English (en)
Inventor
Jin-Emon Konishi
Co Ltd - Kinash Pharmaceutical
Giichi Hamada
Co Ltd - -Chome Pharmaceutical
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE94401T1 publication Critical patent/ATE94401T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT89810317T 1988-04-30 1989-04-27 Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon. ATE94401T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10859088 1988-04-30
EP89810317A EP0341209B1 (de) 1988-04-30 1989-04-27 Physiologisch wirkende Substanzen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen davon

Publications (1)

Publication Number Publication Date
ATE94401T1 true ATE94401T1 (de) 1993-10-15

Family

ID=14488665

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89810317T ATE94401T1 (de) 1988-04-30 1989-04-27 Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.

Country Status (5)

Country Link
EP (1) EP0341209B1 (de)
JP (1) JP2673719B2 (de)
AT (1) ATE94401T1 (de)
DE (1) DE68909100T2 (de)
ES (1) ES2059816T3 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2588109B2 (ja) * 1993-03-19 1997-03-05 日本臓器製薬株式会社 鎮痛剤
JP3213831B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定方法
JP3213832B2 (ja) * 1993-08-06 2001-10-02 日本臓器製薬株式会社 被検物質の活性測定法
JP2594222B2 (ja) * 1993-09-28 1997-03-26 日本臓器製薬株式会社 新規生理活性物質−ｋｆ
JP4033936B2 (ja) * 1997-01-08 2008-01-16 日本臓器製薬株式会社 一酸化窒素産生抑制剤
JPH1180005A (ja) * 1997-09-12 1999-03-23 Nippon Zoki Pharmaceut Co Ltd 骨粗鬆症治療剤
KR19990044835A (ko) 1997-11-28 1999-06-25 고니시 진우에몬 생약추출물
KR20010020741A (ko) 1999-04-15 2001-03-15 고니시 진우에몬 신규의 생체 활성화 물질
KR20010082721A (ko) 2000-02-18 2001-08-30 고니시 진우에몬 지방산 함유 조성물
US6913900B2 (en) 2001-08-29 2005-07-05 Nippon Zoki Pharmaceutical Co., Ltd. Plasma prekallikrein activation and kallikrein production assay
CN1207005C (zh) * 2002-10-31 2005-06-22 威世药业（如皋）有限公司 含生物活性物质的兔皮和其用途
KR101307999B1 (ko) 2004-12-01 2013-09-12 니폰 조키 세야쿠 가부시키가이샤 건조물 및 그 제조방법
US20060134646A1 (en) 2004-12-17 2006-06-22 Ansari Aftab A Method for treatment of HIV infection
CA2909234C (en) 2013-04-30 2023-03-14 Nippon Zoki Pharmaceutical Co., Ltd. Extracts and preparation thereof from inflamed skins of rabbits inoculated with vaccinia virus
WO2021072724A1 (zh) * 2019-10-18 2021-04-22 沛尔生技医药股份有限公司 肽及其作为制备治疗发炎性疾病及疼痛的药物的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5587724A (en) * 1978-12-27 1980-07-02 Nippon Zoki Pharmaceut Co Ltd Selective immune enhancer
JPS5775991A (en) * 1980-10-27 1982-05-12 Nippon Zoki Pharmaceut Co Ltd Novel physiologically active substance jcv-80
JPS5777697A (en) * 1980-11-04 1982-05-15 Nippon Zoki Pharmaceut Co Ltd Physiologically active substance nsq
JPS5835117A (ja) * 1981-08-25 1983-03-01 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質ｎｓｈ
JPS59118711A (ja) * 1982-12-25 1984-07-09 Nippon Zoki Pharmaceut Co Ltd 新規生理活性物質
JP2651674B2 (ja) * 1987-07-23 1997-09-10 日本臓器製薬 株式会社 新規生理活性物質及びその製造方法
US4985254A (en) * 1987-11-06 1991-01-15 Nippon Zoki Pharmaceutical Co., Ltd. Method of treating ischemic diseases

Also Published As

Publication number Publication date
DE68909100T2 (de) 1994-01-13
ES2059816T3 (es) 1994-11-16
EP0341209B1 (de) 1993-09-15
EP0341209A2 (de) 1989-11-08
EP0341209A3 (en) 1990-05-09
JPH0228115A (ja) 1990-01-30
JP2673719B2 (ja) 1997-11-05
DE68909100D1 (de) 1993-10-21

Similar Documents

Publication Publication Date Title
ATE94401T1 (de) Physiologisch wirkende substanzen, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen davon.
DE3876877D1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
CA2093806A1 (en) Method of treating or preventing type 1 diabetes by oral administration of insulin
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
IT1191674B (it) Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
DE58906926D1 (de) Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung.
EP2269648A3 (de) Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
ATE108657T1 (de) Galanthemin enthaltende pharmazeutische formulierung zur behandlung des alkoholismus.
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
ES2103311T3 (es) Compuestos heterociclicos.
ATE237610T1 (de) Substituierte dimere carboxamid-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen
IT8767057A0 (it) Composizioni farmaceutiche a cessione prolungata relative forme di dosaggio e procedimento per la loro preparazione
DE3764235D1 (de) Ifosfamid-lyophilisat und verfahren zu dessen herstellung.
DE69003466D1 (de) Substituierte Thienopyrimidin-Derivate, deren Herstellung, pharmazeutische Zusammensetzungen und medizinische Verwendung.
IT1204571B (it) Esteri di 1,4:3,6-dianidrosorbitolo-2-mononitrato e 5-mononitrato,loro procedimento di preparazione e loro composizioni farmaceutiche
UA39118C2 (uk) Похідні бензоїлгуанідину, спосіб їх отримання, фармацевтична композиція та спосіб її отримання
CA2070169A1 (en) Compounds with a sequence of three radicals, the central one being -aminoacidic and therapeutical applications thereof
EP0355899A3 (de) Nucleotid-Derivate
ATE60333T1 (de) D-nor-7-ergolinderivate, verfahren zu ihrer herstellung, pharmazeutische zubereitung und verwendung.
FR2610322B1 (fr) Nouveaux derives de la pilocarpine, leur preparation et leur utilisation comme medicaments
ATE130190T1 (de) Ein dihydropyridinderivat in nanosolform enthaltendes retard-arzneimittel und seine herstellung.
DE3764233D1 (de) Cyclopentylaether, deren herstellung und pharmazeutische formulierung.
DE3773128D1 (de) Cyclopentanaether, ihre herstellung und pharmazeutische formulierung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee